pmjТихоокеанский медицинский журналPacific Medical Journal1609-1175TGMUpmj-1568Research ArticleОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯORIGINAL RESEARCHESШЕСТИЛЕТНИЙ ОПЫТ ИСПОЛЬЗОВАНИЯ АВТОМАТИЧЕСКИХ ИМПЛАНТИРУЕМЫХ КАРДИОВЕРТЕРОВ-ДЕФИБРИЛЛЯТОРОВSIX-YEAR EXPERIENCE OF USE OF THE AUTOMATIC IMPLANTED CARDIOVERTERS-DEFIBRILLATORSКриволаповС. Н.KrivolapovS. N.ПоповС. В.PopovS. V.АнтонченкоИ. В.AntonchenkoI. V.ПлехановИ. Г.PlehanovI. G.БаталовР. Е.BatalovR. E.НИИ кардиологии Томского НЦ СО РАМНРоссияScientific research institute of cardiology of the Tomsk Scientific Centre of RAMSRussian Federation200728032007012930Copyright © Криволапов С.Н., Попов С.В., Антонченко И.В., Плеханов И.Г., Баталов Р.Е., 20072007Криволапов С.Н., Попов С.В., Антонченко И.В., Плеханов И.Г., Баталов Р.Е.Krivolapov S.N., Popov S.V., Antonchenko I.V., Plehanov I.G., Batalov R.E.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.tmj-vgmu.ru/jour/article/view/1568

.

The analysis of efficiency of the automatic implanted cardioverters-defibrillators at 32 patients with risk of sudden cardiac death (ischemic heart disease, dilatation cardiomiopathy, etc.) is done. Triggering of devices has been fixed at 85.7% of patients at which implantation was a measure of secondary prophylaxis. From primary prophylaxis group of sudden cardiac death (7 cases) triggering has been fixed in 1 case (14.3%). Thus, implantation of the cardioverters-defibrillators as a measure of secondary prophylaxis is absolutely justified.

кардиовертер-дефибрилляторвнезапная сердечная смертьReferencesCannom D.S., Prystowsky E.N. // JAMA. - 1999. - Vol. 281. - P. 172-179.Cannom D.S., Prystowsky E.N. // JAMA. - 1999. - Vol. 281. - P. 172-179.Higgins S.L., Hummel J.D., Niazi I.K. et al. // J. Am. Coll. Cardiol. - 2003. - Vol. 42. - P. 1454-1459.Higgins S.L., Hummel J.D., Niazi I.K. et al. // J. Am. Coll. Cardiol. - 2003. - Vol. 42. - P. 1454-1459.Moss A.J., Hall W.J., Cannom D.S. et al. //N. Engl. J. Med. - 1996. - Vol. 335. - P. 1933-1940.Moss A.J., Hall W.J., Cannom D.S. et al. //N. Engl. J. Med. - 1996. - Vol. 335. - P. 1933-1940.Moss A.J., Zareba W., Hall W.J. et al. // N. Engl. J. Med. - 2002. - Vol. 346. - P. 877-883.Moss A.J., Zareba W., Hall W.J. et al. // N. Engl. J. Med. - 2002. - Vol. 346. - P. 877-883.Moss A., Zareba W., Hall W.J. et al. //N. Eng. J. Med. - 2002. - Vol. 346. - P. 877-883.Moss A., Zareba W., Hall W.J. et al. //N. Eng. J. Med. - 2002. - Vol. 346. - P. 877-883.Prystowsky E.N. // Rev. Cardiovasc. Med. - 2001. - Vol. 2. - P. 197-205.Prystowsky E.N. // Rev. Cardiovasc. Med. - 2001. - Vol. 2. - P. 197-205.State-specific mortality from sudden cardiac death. — United States, 1999 // MMWR Morb. Mortal Wkly Rep. - 2002. - Vol. 51. - P. 123-126.State-specific mortality from sudden cardiac death. — United States, 1999 // MMWR Morb. Mortal Wkly Rep. - 2002. - Vol. 51. - P. 123-126.

The authors declare that there are no conflicts of interest present.